866-997-4948(US-Canada Toll Free)

EMEA (Europe, Middle East and Africa) Substance Abuse Treatment Market Report 2017

Published By :

QYResearch

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 118 Pages

In this report, the EMEA Substance Abuse Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Substance Abuse Treatment for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Substance Abuse Treatment market competition by top manufacturers/players, with Substance Abuse Treatment sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Allergan
GSK
Pfizer
Accord Healthcare
Alkermes
INSYS Therapeutics
Mylan Laboratories
Opiant Technologies
Amphastar Pharmaceuticals
Apotex
BioCorRx
Cipla
Glenmark
Sterinova
Sun Pharma
Teva Pharmaceutical
LFB Group
Lupin
Sanofi Aventis
Sanquin

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Alcohol Abuse Treatment
Nicotine Abuse Treatment
Drug Abuse Treatment

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Substance Abuse Treatment for each application, including
Hospitals
Clinics

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Substance Abuse Treatment Market Report 2017
1 Substance Abuse Treatment Overview
1.1 Product Overview and Scope of Substance Abuse Treatment
1.2 Classification of Substance Abuse Treatment
1.2.1 EMEA Substance Abuse Treatment Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Substance Abuse Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Alcohol Abuse Treatment
1.2.4 Nicotine Abuse Treatment
1.2.5 Drug Abuse Treatment
1.3 EMEA Substance Abuse Treatment Market by Application/End Users
1.3.1 EMEA Substance Abuse Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospitals
1.3.3 Clinics
1.4 EMEA Substance Abuse Treatment Market by Region
1.4.1 EMEA Substance Abuse Treatment Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Substance Abuse Treatment (2012-2022)
1.5.1 EMEA Substance Abuse Treatment Sales and Growth Rate (2012-2022)
1.5.2 EMEA Substance Abuse Treatment Revenue and Growth Rate (2012-2022)

2 EMEA Substance Abuse Treatment Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Substance Abuse Treatment Market Competition by Players/Manufacturers
2.1.1 EMEA Substance Abuse Treatment Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Substance Abuse Treatment Revenue and Share by Players (2012-2017)
2.1.3 EMEA Substance Abuse Treatment Sale Price by Players (2012-2017)
2.2 EMEA Substance Abuse Treatment (Volume and Value) by Type/Product Category
2.2.1 EMEA Substance Abuse Treatment Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Substance Abuse Treatment Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Substance Abuse Treatment Sale Price by Type (2012-2017)
2.3 EMEA Substance Abuse Treatment (Volume) by Application
2.4 EMEA Substance Abuse Treatment (Volume and Value) by Region
2.4.1 EMEA Substance Abuse Treatment Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Substance Abuse Treatment Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Substance Abuse Treatment Sales Price by Region (2012-2017)

3 Europe Substance Abuse Treatment (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Substance Abuse Treatment Sales and Value (2012-2017)
3.1.1 Europe Substance Abuse Treatment Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Substance Abuse Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe Substance Abuse Treatment Sales and Market Share by Type
3.3 Europe Substance Abuse Treatment Sales and Market Share by Application
3.4 Europe Substance Abuse Treatment Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Substance Abuse Treatment Sales Volume by Countries (2012-2017)
3.4.2 Europe Substance Abuse Treatment Revenue by Countries (2012-2017)
3.4.3 Germany Substance Abuse Treatment Sales and Growth Rate (2012-2017)
3.4.4 France Substance Abuse Treatment Sales and Growth Rate (2012-2017)
3.4.5 UK Substance Abuse Treatment Sales and Growth Rate (2012-2017)
3.4.6 Russia Substance Abuse Treatment Sales and Growth Rate (2012-2017)
3.4.7 Italy Substance Abuse Treatment Sales and Growth Rate (2012-2017)
3.4.8 Benelux Substance Abuse Treatment Sales and Growth Rate (2012-2017)

4 Middle East Substance Abuse Treatment (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Substance Abuse Treatment Sales and Value (2012-2017)
4.1.1 Middle East Substance Abuse Treatment Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Substance Abuse Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East Substance Abuse Treatment Sales and Market Share by Type
4.3 Middle East Substance Abuse Treatment Sales and Market Share by Application
4.4 Middle East Substance Abuse Treatment Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Substance Abuse Treatment Sales Volume by Countries (2012-2017)
4.4.2 Middle East Substance Abuse Treatment Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Substance Abuse Treatment Sales and Growth Rate (2012-2017)
4.4.4 Israel Substance Abuse Treatment Sales and Growth Rate (2012-2017)
4.4.5 UAE Substance Abuse Treatment Sales and Growth Rate (2012-2017)
4.4.6 Iran Substance Abuse Treatment Sales and Growth Rate (2012-2017)

5 Africa Substance Abuse Treatment (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Substance Abuse Treatment Sales and Value (2012-2017)
5.1.1 Africa Substance Abuse Treatment Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Substance Abuse Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa Substance Abuse Treatment Sales and Market Share by Type
5.3 Africa Substance Abuse Treatment Sales and Market Share by Application
5.4 Africa Substance Abuse Treatment Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Substance Abuse Treatment Sales Volume by Countries (2012-2017)
5.4.2 Africa Substance Abuse Treatment Revenue by Countries (2012-2017)
5.4.3 South Africa Substance Abuse Treatment Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Substance Abuse Treatment Sales and Growth Rate (2012-2017)
5.4.5 Egypt Substance Abuse Treatment Sales and Growth Rate (2012-2017)
5.4.6 Algeria Substance Abuse Treatment Sales and Growth Rate (2012-2017)

6 EMEA Substance Abuse Treatment Manufacturers/Players Profiles and Sales Data
6.1 Allergan
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Substance Abuse Treatment Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Allergan Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GSK
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Substance Abuse Treatment Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GSK Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Substance Abuse Treatment Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Accord Healthcare
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Substance Abuse Treatment Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Accord Healthcare Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Alkermes
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Substance Abuse Treatment Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Alkermes Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 INSYS Therapeutics
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Substance Abuse Treatment Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 INSYS Therapeutics Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Mylan Laboratories
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Substance Abuse Treatment Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Mylan Laboratories Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Opiant Technologies
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Substance Abuse Treatment Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Opiant Technologies Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Amphastar Pharmaceuticals
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Substance Abuse Treatment Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Amphastar Pharmaceuticals Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Apotex
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Substance Abuse Treatment Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Apotex Substance Abuse Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 BioCorRx
6.12 Cipla
6.13 Glenmark
6.14 Sterinova
6.15 Sun Pharma
6.16 Teva Pharmaceutical
6.17 LFB Group
6.18 Lupin
6.19 Sanofi Aventis
6.20 Sanquin

7 Substance Abuse Treatment Manufacturing Cost Analysis
7.1 Substance Abuse Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Substance Abuse Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Substance Abuse Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Substance Abuse Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Substance Abuse Treatment Market Forecast (2017-2022)
11.1 EMEA Substance Abuse Treatment Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Substance Abuse Treatment Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Substance Abuse Treatment Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Substance Abuse Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA Substance Abuse Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Substance Abuse Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Substance Abuse Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Substance Abuse Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Substance Abuse Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA Substance Abuse Treatment Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Substance Abuse Treatment
Figure EMEA Substance Abuse Treatment Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Substance Abuse Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Alcohol Abuse Treatment Product Picture
Figure Nicotine Abuse Treatment Product Picture
Figure Drug Abuse Treatment Product Picture
Figure EMEA Substance Abuse Treatment Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Substance Abuse Treatment by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure EMEA Substance Abuse Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Substance Abuse Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Substance Abuse Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Substance Abuse Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Substance Abuse Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Substance Abuse Treatment Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Substance Abuse Treatment Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Substance Abuse Treatment Sales Share by Players (2012-2017)
Figure 2016 Substance Abuse Treatment Sales Share by Players
Figure 2017 Substance Abuse Treatment Sales Share by Players
Figure EMEA Substance Abuse Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Substance Abuse Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA Substance Abuse Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA Substance Abuse Treatment Revenue Share by Players
Table 2017 EMEA Substance Abuse Treatment Revenue Share by Players
Table EMEA Substance Abuse Treatment Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Substance Abuse Treatment Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Substance Abuse Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Substance Abuse Treatment by Type (2012-2017)
Figure EMEA Substance Abuse Treatment Sales Market Share by Type (2012-2017)
Table EMEA Substance Abuse Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Substance Abuse Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Substance Abuse Treatment by Type in 2016
Table EMEA Substance Abuse Treatment Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Substance Abuse Treatment Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Substance Abuse Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Substance Abuse Treatment by Application (2012-2017)
Figure EMEA Substance Abuse Treatment Sales Market Share by Application in 2016
Table EMEA Substance Abuse Treatment Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Substance Abuse Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Substance Abuse Treatment by Region (2012-2017)
Figure EMEA Substance Abuse Treatment Sales Market Share in 2016
Table EMEA Substance Abuse Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Substance Abuse Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Substance Abuse Treatment by Region (2012-2017)
Figure EMEA Substance Abuse Treatment Revenue Market Share Regions in 2016
Table EMEA Substance Abuse Treatment Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Substance Abuse Treatment Revenue and Growth Rate (2012-2017)
Table Europe Substance Abuse Treatment Sales (K MT) by Type (2012-2017)
Table Europe Substance Abuse Treatment Market Share by Type (2012-2017)
Figure Europe Substance Abuse Treatment Market Share by Type in 2016
Table Europe Substance Abuse Treatment Sales (K MT) by Application (2012-2017)
Table Europe Substance Abuse Treatment Market Share by Application (2012-2017)
Figure Europe Substance Abuse Treatment Market Share by Application in 2016
Table Europe Substance Abuse Treatment Sales (K MT) by Countries (2012-2017)
Table Europe Substance Abuse Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Substance Abuse Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Substance Abuse Treatment Sales Market Share by Countries in 2016
Table Europe Substance Abuse Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe Substance Abuse Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Substance Abuse Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Substance Abuse Treatment Revenue Market Share by Countries in 2016
Figure Germany Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure France Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure UK Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Substance Abuse Treatment Sales (K MT) by Type (2012-2017)
Table Middle East Substance Abuse Treatment Market Share by Type (2012-2017)
Figure Middle East Substance Abuse Treatment Market Share by Type (2012-2017)
Table Middle East Substance Abuse Treatment Sales (K MT) by Applications (2012-2017)
Table Middle East Substance Abuse Treatment Market Share by Applications (2012-2017)
Figure Middle East Substance Abuse Treatment Sales Market Share by Application in 2016
Table Middle East Substance Abuse Treatment Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Substance Abuse Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Substance Abuse Treatment Sales Volume Market Share by Countries in 2016
Table Middle East Substance Abuse Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East Substance Abuse Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Substance Abuse Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Substance Abuse Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Substance Abuse Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Substance Abuse Treatment Sales (K MT) by Type (2012-2017)
Table Africa Substance Abuse Treatment Sales Market Share by Type (2012-2017)
Figure Africa Substance Abuse Treatment Sales Market Share by Type (2012-2017)
Figure Africa Substance Abuse Treatment Sales Market Share by Type in 2016
Table Africa Substance Abuse Treatment Sales (K MT) by Application (2012-2017)
Table Africa Substance Abuse Treatment Sales Market Share by Application (2012-2017)
Figure Africa Substance Abuse Treatment Sales Market Share by Application (2012-2017)
Table Africa Substance Abuse Treatment Sales Volume (K MT) by Countries (2012-2017)
Table Africa Substance Abuse Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Substance Abuse Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Substance Abuse Treatment Sales Market Share by Countries in 2016
Table Africa Substance Abuse Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa Substance Abuse Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Substance Abuse Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Substance Abuse Treatment Revenue Market Share by Countries in 2016
Figure South Africa Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Table Allergan Substance Abuse Treatment Basic Information List
Table Allergan Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Allergan Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Allergan Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Allergan Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table GSK Substance Abuse Treatment Basic Information List
Table GSK Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GSK Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure GSK Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure GSK Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table Pfizer Substance Abuse Treatment Basic Information List
Table Pfizer Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Pfizer Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table Accord Healthcare Substance Abuse Treatment Basic Information List
Table Accord Healthcare Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Accord Healthcare Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table Alkermes Substance Abuse Treatment Basic Information List
Table Alkermes Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Alkermes Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Alkermes Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Alkermes Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table INSYS Therapeutics Substance Abuse Treatment Basic Information List
Table INSYS Therapeutics Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure INSYS Therapeutics Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure INSYS Therapeutics Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure INSYS Therapeutics Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table Mylan Laboratories Substance Abuse Treatment Basic Information List
Table Mylan Laboratories Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Laboratories Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Mylan Laboratories Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Mylan Laboratories Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table Opiant Technologies Substance Abuse Treatment Basic Information List
Table Opiant Technologies Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Opiant Technologies Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Opiant Technologies Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Opiant Technologies Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table Amphastar Pharmaceuticals Substance Abuse Treatment Basic Information List
Table Amphastar Pharmaceuticals Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Amphastar Pharmaceuticals Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table Apotex Substance Abuse Treatment Basic Information List
Table Apotex Substance Abuse Treatment Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Apotex Substance Abuse Treatment Sales (K MT) and Growth Rate (2012-2017)
Figure Apotex Substance Abuse Treatment Sales Market Share in EMEA (2012-2017)
Figure Apotex Substance Abuse Treatment Revenue Market Share in EMEA (2012-2017)
Table BioCorRx Substance Abuse Treatment Basic Information List
Table Cipla Substance Abuse Treatment Basic Information List
Table Glenmark Substance Abuse Treatment Basic Information List
Table Sterinova Substance Abuse Treatment Basic Information List
Table Sun Pharma Substance Abuse Treatment Basic Information List
Table Teva Pharmaceutical Substance Abuse Treatment Basic Information List
Table LFB Group Substance Abuse Treatment Basic Information List
Table Lupin Substance Abuse Treatment Basic Information List
Table Sanofi Aventis Substance Abuse Treatment Basic Information List
Table Sanquin Substance Abuse Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Substance Abuse Treatment
Figure Manufacturing Process Analysis of Substance Abuse Treatment
Figure Substance Abuse Treatment Industrial Chain Analysis
Table Raw Materials Sources of Substance Abuse Treatment Major Manufacturers in 2016
Table Major Buyers of Substance Abuse Treatment
Table Distributors/Traders List
Figure EMEA Substance Abuse Treatment Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Substance Abuse Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Substance Abuse Treatment Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Substance Abuse Treatment Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Substance Abuse Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA Substance Abuse Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Substance Abuse Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe Substance Abuse Treatment Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Substance Abuse Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe Substance Abuse Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Substance Abuse Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Substance Abuse Treatment Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Substance Abuse Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Substance Abuse Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Substance Abuse Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Substance Abuse Treatment Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Substance Abuse Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa Substance Abuse Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Substance Abuse Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Substance Abuse Treatment Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Substance Abuse Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA Substance Abuse Treatment Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Substance Abuse Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *